Newborn Screening for Primary Immunodeficiencies: Focus on Severe Combined Immunodeficiency (SCID) and Other Severe T-Cell Lymphopenias

Borte, Stephan; Reichenbach, Janine

doi:10.3390/ijns1030089

Submit to this Journal Review for this Journal Edit a Special Issue

Article Menu

...

Open AccessReview

Newborn Screening for Primary Immunodeficiencies: Focus on Severe Combined Immunodeficiency (SCID) and Other Severe T-Cell Lymphopenias

Stephan Borte

^1,2 and

Janine Reichenbach

^3,4,*

Immuno Deficiency Center Leipzig (IDCL), St. Georg hospital, 04129 Leipzig, Germany

Translational Center for Regenerative Medicine (TRM) Leipzig, University Leipzig, 04103 Leipzig, Germany

Division of Immunology, University Children’s Hospital and Children’s Research Center, Steinwiesstrasse 75, CH-8032 Zurich, Switzerland

⁴

University of Zurich, Rämistrasse 71, 8006 Zurich, Switzerland

Author to whom correspondence should be addressed.

Academic Editor: Peter C.J.I. Schielen

Int. J. Neonatal Screen. 2015, 1(3), 89-100; https://doi.org/10.3390/ijns1030089

Received: 28 April 2015 / Revised: 29 October 2015 / Accepted: 4 November 2015 / Published: 16 December 2015

View Full-Text Download PDF

Browse Figures

Citation Export

Abstract

Primary immunodeficiencies (PID) are congenital disorders of immune competence, which are mainly characterized by a pathological susceptibility to infection. More than 240 PID disease entities have been defined so far, accounting for a broad spectrum of clinical symptoms and severity. Severe PID are increasingly becoming appreciated as a relevant health problem, and diagnostic procedures and screening profiles to allow earliest possible diagnosis on a population scale have already been developed in the USA and few European countries. The most severe PID are characterized by significant mortality in the first years of life, as well as serious morbidity with irreversible organ damage. This applies in particular to PID that are defined by the absence or functional anergy of T-lymphocytes (severe combined immunodeficiency; SCID) or B-lymphocytes (e.g., X-linked agammaglobulinemia; XLA). A strategy to improve the outcome of severe PID by prompt diagnosis and immediate adequate treatment is screening newborns for the presence of T and B cells. View Full-Text

Keywords: severe combined immunodeficiency (SCID); T-cell lymphopenia; T-cell receptor excision circles (TRECs); kappa-deleting element recombination circles (KRECs); Newborn screening (NBS); hematopoietic stem cell transplantation (HSCT); gene therapy (GT)

▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Share and Cite

MDPI and ACS Style

Borte, S.; Reichenbach, J. Newborn Screening for Primary Immunodeficiencies: Focus on Severe Combined Immunodeficiency (SCID) and Other Severe T-Cell Lymphopenias. Int. J. Neonatal Screen. 2015, 1, 89-100. https://doi.org/10.3390/ijns1030089

AMA Style

Borte S, Reichenbach J. Newborn Screening for Primary Immunodeficiencies: Focus on Severe Combined Immunodeficiency (SCID) and Other Severe T-Cell Lymphopenias. International Journal of Neonatal Screening. 2015; 1(3):89-100. https://doi.org/10.3390/ijns1030089

Chicago/Turabian Style

Borte, Stephan; Reichenbach, Janine. 2015. "Newborn Screening for Primary Immunodeficiencies: Focus on Severe Combined Immunodeficiency (SCID) and Other Severe T-Cell Lymphopenias" Int. J. Neonatal Screen. 1, no. 3: 89-100. https://doi.org/10.3390/ijns1030089

Find Other Styles

Article Metrics

Abstract views Pdf views Html views

Article Menu

Newborn Screening for Primary Immunodeficiencies: Focus on Severe Combined Immunodeficiency (SCID) and Other Severe T-Cell Lymphopenias

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Article Access Map by Country/Region

Further Information

Guidelines

MDPI Initiatives

Follow MDPI